Use of Diazepam in Neonatal Narcotic Withdrawal Syndrome
1 Department of Pediatrics, Darnall Army Hospital, Fort Hood, Texas 76544
I read with interest and concern the recent article1 by Drs. Nathenson, Golden, and Litt concerning the use of diazepam in the neonatal narcotic withdrawal syndrome. Another recent article in your journal2 points out that diazepam for parental use contains sodium benzoate. Sodium benzoate has the capacity to interfere with bilirubin-albumin binding. There are many other good drugs that the physician may use (paregoric, chlorpromazine, phenobarbital3,4) without theoretically increasing the risk of kernicterus, and perhaps the use of diazepam in the neonatal period for narcotic withdrawal would best be avoided, at least until further information is available.
This article has been cited by other articles:
![]() |
Committee on Drugs Neonatal Drug Withdrawal. Pediatrics, June 1, 1998; 101(6): 1079 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Quillian II and C. A. Dunn Neonatal Drug Withdrawal From Propoxyphene JAMA, May 10, 1976; 235(19): 2128 - 2128. [Abstract] [PDF] |
||||







